DSIP
L-tryptophyl-L-alanyl-glycyl-glycyl-L-aspartyl-L-alanyl-L-seryl-glycyl-L-glutamic acid
DSIP is a naturally occurring nonapeptide identified in 1977 from rabbit cerebral venous blood, comprising nine amino acids in the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. This linear, hydrophilic peptide maintains its endogenous structure without synthetic modifications, making it ideal for sleep regulation research, stress response modulation, and central nervous system function studies in controlled experimental settings.
Complete Dosing Guide
Possible Side Effects
Common Side Effects (Generally Mild):
- Transient headache
- Mild dizziness or vertigo
- Nausea (rare)
- Injection site reactions (redness, minor pain)
- Daytime drowsiness at higher doses
⚠️Rare Side Effects:
- Moderate to severe drop in blood pressure
- Extended grogginess (with excessive dosing)
- Gastrointestinal discomfort
Note: DSIP is considered "incredibly safe" with no reported deaths in animal studies and minimal side effects in human trials.
Medical Disclaimer
DSIP is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.